These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1020 related articles for article (PubMed ID: 6703733)

  • 1. Subacute cutaneous lupus erythematosus and discoid lupus erythematosus. Comparative histopathologic findings.
    Bangert JL; Freeman RG; Sontheimer RD; Gilliam JN
    Arch Dermatol; 1984 Mar; 120(3):332-7. PubMed ID: 6703733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic comparison of the subsets of lupus erythematosus.
    Jerdan MS; Hood AF; Moore GW; Callen JP
    Arch Dermatol; 1990 Jan; 126(1):52-5. PubMed ID: 2404463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus.
    David-Bajar KM; Bennion SD; DeSpain JD; Golitz LE; Lee LA
    J Invest Dermatol; 1992 Sep; 99(3):251-7. PubMed ID: 1512459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
    Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C
    Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset.
    Sontheimer RD; Thomas JR; Gilliam JN
    Arch Dermatol; 1979 Dec; 115(12):1409-15. PubMed ID: 533284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical aspects and differential diagnosis of cutaneous lupus erythematosus].
    Kind P; Goerz G
    Z Hautkr; 1987 Sep; 62(18):1337-8, 1341-2, 1347. PubMed ID: 3687157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus.
    Ishikawa O; Zaw KK; Miyachi Y; Hashimoto T; Tanaka T
    Br J Dermatol; 1997 Feb; 136(2):222-6. PubMed ID: 9068736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-17 in cutaneous lupus erythematosus.
    Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
    Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus.
    Schmitt V; Meuth AM; Amler S; Kuehn E; Haust M; Messer G; Bekou V; Sauerland C; Metze D; Köpcke W; Bonsmann G; Kuhn A
    Br J Dermatol; 2010 Jan; 162(1):64-73. PubMed ID: 19712116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus.
    Järvinen TM; Hellquist A; Koskenmies S; Einarsdottir E; Koskinen LL; Jeskanen L; Berglind L; Panelius J; Hasan T; Ranki A; Kere J; Saarialho-Kere U
    Exp Dermatol; 2010 Feb; 19(2):123-31. PubMed ID: 19758313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
    Walling HW; Sontheimer RD
    Am J Clin Dermatol; 2009; 10(6):365-81. PubMed ID: 19824738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD40/CD40 ligand system in the skin of patients with subacute cutaneous lupus erythematosus.
    Caproni M; Torchia D; Antiga E; Giomi B; Mercuri M; Volpi W; Fabbri P
    J Rheumatol; 2007 Dec; 34(12):2412-6. PubMed ID: 18050371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of lupus erythematosus based upon Japanese patients.
    Tsuchida T
    Autoimmun Rev; 2009 May; 8(6):453-5. PubMed ID: 19162249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin CD4
    Zhao Z; Zhu H; Li Q; Liao W; Chen K; Yang M; Long D; He Z; Zhao M; Wu H; Lu Q
    J Autoimmun; 2022 Apr; 128():102811. PubMed ID: 35278775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis.
    Magro CM; Segal JP; Crowson AN; Chadwick P
    J Cutan Pathol; 2010 Jun; 37(6):659-71. PubMed ID: 19891658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus.
    Järvinen TM; Kanninen P; Jeskanen L; Koskenmies S; Panelius J; Hasan T; Ranki A; Saarialho-Kere U
    Br J Dermatol; 2007 Nov; 157(5):970-80. PubMed ID: 17854363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous manifestations of systemic lupus erythematosus.
    Yell JA; Mbuagbaw J; Burge SM
    Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry of ultrastructural changes in scarring lupus erythematosus.
    Al-Refu K; Goodfield M
    Clin Exp Dermatol; 2011 Jan; 36(1):63-8. PubMed ID: 20637030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lupus erythematosus].
    Goerz G; Lehmann P; Schuppe HC; Lakomek HJ; Kind P
    Z Hautkr; 1990 Mar; 65(3):226, 229-34. PubMed ID: 2339576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus.
    Li Q; Wu H; Liao W; Zhao M; Chan V; Li L; Zheng M; Chen G; Zhang J; Lau CS; Lu Q
    J Autoimmun; 2018 Sep; 93():1-15. PubMed ID: 30017673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.